Coenzyme Q9(Synonyms: 辅酶Q9; Ubiquinone Q9; CoQ9; Ubiquinone 9)

天然产物醌类Quinones

Coenzyme Q9 (Synonyms: 辅酶Q9; Ubiquinone Q9; CoQ9; Ubiquinone 9) 纯度: ≥98.0%

Coenzyme Q9 (Ubiquinone Q9) 是啮齿类动物泛醌的主要形式,是电子传递链中的一种双亲分子组分,具有内源性抗氧化剂的作用。Coenzyme Q9 可减轻糖尿病引起的抗氧化防御机制的下降。Coenzyme Q9 改善左心室功能,减少心肌梗死面积和心肌细胞凋亡。

Coenzyme Q9(Synonyms: 辅酶Q9; Ubiquinone Q9;  CoQ9;  Ubiquinone 9)

Coenzyme Q9 Chemical Structure

CAS No. : 303-97-9

规格 价格 是否有货 数量
1 mg ¥550 In-stock
5 mg ¥2200 In-stock
10 mg ¥3850 In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Coenzyme Q9 相关产品

相关化合物库:

  • Natural Product Library Plus
  • Bioactive Compound Library Plus
  • Apoptosis Compound Library
  • Metabolism/Protease Compound Library
  • Natural Product Library
  • Human Endogenous Metabolite Compound Library
  • Diabetes Related Compound Library
  • Anti-Cardiovascular Disease Compound Library
  • Orally Active Compound Library
  • Traditional Chinese Medicine Monomer Library
  • FDA Approved & Pharmacopeial Drug Library
  • Glucose Metabolism Compound Library
  • Food-Sourced Compound Library

生物活性

Coenzyme Q9 (Ubiquinone Q9), the major form of ubiquinone in rodents, is an amphipathic molecular component of the electron transport chain that functions as an endogenous antioxidant. Coenzyme Q9 attenuates the diabetes-induced decreases in antioxidant defense mechanisms. Coenzyme Q9 improves left ventricular performance and reduces myocardial infarct size and cardiomyocyte apoptosis[1][2].

IC50 & Target

Human Endogenous Metabolite

 

体内研究
(In Vivo)

Coenzyme Q9 (5 mg/kg; p.o.; once a day for 4 weeks) reduces myocardial ischemia/reperfusion injury[2].
CoQ10 and CoQ9 are components of themitochondrial respiratory chain in mammals and can regulate some mitochondrial proteins/functions. Soybean, corn, and rapeseed oils are very rich sources of CoQ10, whereas CoQ9 has been found in high concentrations in corn oil[3].
The lack of a functional CoQ9 protein in homozygous CoQ9 mutant (CoQ9(X/X)) mice causes a severe reduction in the CoQ7 protein and a widespread CoQ deficiency and accumulation of demethoxyubiquinone. The deficit in CoQ induces a brain-specific impairment of mitochondrial bioenergetics performance, a reduction in respiratory control ratio, ATP levels and ATP/ADP ratio and specific loss of respiratory complex I. These effects lead to neuronal death and demyelinization with severe vacuolization and astrogliosis in the brain of CoQ9 (X/X) mice that consequently die between 3 and 6 months of age[4].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Hartley guinea pigs of about 350-400 g body weight[2]
Dosage: 5 mg/kg of body weight
Administration: P.o.; once a day for 4 weeks
Result: Nutritional supplementation of CoQ9 can reduce myocardial ischemia/reperfusion injury to the same extent as CoQ10.

分子量

795.23

Formula

C54H82O4

CAS 号

303-97-9

中文名称

辅酶Q9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
In Vitro: 

Ethanol : 33.33 mg/mL (41.91 mM; Need ultrasonic)

DMSO : 2 mg/mL (2.51 mM; ultrasonic and warming and heat to 80°C)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.2575 mL 6.2875 mL 12.5750 mL
5 mM 0.2515 mL 1.2575 mL 2.5150 mL
10 mM 0.1257 mL 0.6287 mL 1.2575 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

参考文献
  • [1]. Wold LE, et al. Insulin-like growth factor I (IGF-1) supplementation prevents diabetes-induced alterations in coenzymes Q9 and Q10. Acta Diabetol. 2003;40(2):85-90.

    [2]. Lekli I, et al. Coenzyme Q9 provides cardioprotection after converting into coenzyme Q10. J Agric Food Chem. 2008 Jul 9;56(13):5331-7.

    [3]. Venegas C, et al. Determination of coenzyme Q10, coenzyme Q9, and melatonin contents in virgin argan oils: comparison with other edible vegetable oils. J Agric Food Chem. 2011 Nov 23;59(22):12102-8.

    [4]. García-Corzo L, et al. Dysfunctional Coq9 protein causes predominant encephalomyopathy associated with CoQ deficiency. Hum Mol Genet. 2013 Mar 15;22(6):1233-48.